Amanda Corbett

Document Actions

Presentations

1.  Corbett A,  Hosseinipour M, Nyirenda J, Knayama C, Mshali I, Chinyama S, Lyke A, Rezk N, Hoffman I, Kashbua A, Mwansambo C, Weigel R, Kazembe P. Pharmacokinetics (PK) Of Trade and Generic Liquid and Split Tablet Formulations of Lamivudine, Stavudine, and Nevirapine in HIV-Infected Malawian Children. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC 2005 [Poster H-1106]. 

2. Hosseinipour, MC, Corbett AH, Kanyama C, Mshali I, Chinyama S, Phakati S, Rezk N, White S, Hoffman I, Van der Horst C, Kashuba ADM. Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine, and nevirapine in HIV-infected Malawian subjects.  12th Conference on Retroviruses and Opportunistic Infections, Boston, MA 2005 [Poster 631].

3. Corbett AH, Davidson L, Park J, Patterson K, Eron JJ, Ngo L, Lim ML, Shelton M, Wire MB, and Kashuba ADM. Dose separation strategies to overcome the pharmacokinetic (PK) interaction of a triple protease inhibitor regimen containing fosamprenavir (908), lopinavir (LPV), and ritonavir (RTV).  11th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA 2004 [Poster 611].

4. Corbett AH, Eron JJ, Fiscus SA, Rezk N, and Kashuba A.  Pharmacokinetics, Efficacy, and Safety of a Triple Protease Inhibitor Salvage Regimen Containing Amprenavir/Saquinavir/Ritonavir. American College of Clinical Pharmacy, Annual Meeting, Atlanta, GA 2003 [Platform Presentation].

5. Corbett A, Eron J, Diebold M, Fiscus S, Rezk N, Kashuba A.  Short-term 
         Safety and Efficacy of An Amprenavir [APV] /Saquinavir [SQV] /Ritonavir [RTV]  
         Salvage Regimen. Infectious Diseases Society of America, Chicago, IL 2002 [Poster 450].

6. Corbett A, Eron J, Rezk N, Diebold M, Kashuba A. A Triple Protease Inhibitor  
         [PI] Salvage Regimen of Amprenavir [APV] + Saquinavir [SQV] + Ritonavir  
         [RTV]: Steady State [SS] Pharmacokinetics [PK] and Initial RNA and CD4
         Response. World AIDS Conference, Barcelona, Spain 2002 [Poster 4464].

7. Min SS, Corbett AH, Rezk N, Fiscus SA, Cohen MS, Kashuba ADM.
         Differential Penetration of Protease Inhibitors [PI] and Non-Nucleoside Reverse
         Transcriptase Inhibitors [NNRTI] into the Female Genital Tract [GT]. World
         AIDS Conference, Barcelona, Spain 2002 [Poster 5966].

8. Kashuba ADM, Min SS, Corbett AH, Rezk N, Cohen MS. Comparison of 
         Protease Inhibitor [PI] and Non-Nucleoside Reverse Transcriptase Inhibitor
         [NNRTI] Concentrations [CONC] in the Male [M] and Female [F] Genital Tract
         [GT]. 3rd International Workshop on Clinical Pharmacology of HIV Therapy,
         Washington DC, 2002 [Poster 5.3].